Why the study?
Does varying citrate concentration affect the prothrombin time test in normal subjects and patients on oral anticoagulants?
Does varying citrate concentration affect the prothrombin time test in normal subjects and patients on oral anticoagulants?
The study demonstrates that varying citrate concentrations affect prothrombin time results, leading to the recommendation of a uniform 3.2% trisodium citrate (0.109 M) concentration.
Answers are grounded in this paper and cite their sources.
Variable citrate concentrations may alter PT results; leaves open optimal uniform standardization for reliable anticoagulation monitoring.
Summary Blood samples from 12 normal subjects and 46 patients on oral anticoagulants were divided so that each was anticoagulated with four concentrations of trisodium citrate solution in the range 0.09–0.15 M, 9 vol blood being added to 1 vol citrate solution in each case. Citrated blood haematocrit and plasma prothrombin time was measured on each subsample; 0.025 M CaCl2-solution was used for recalcification throughout. Three laboratories participated, each using a different prothrombin-time technique. The haematocrit of the citrated blood fell progressively as the molarity of the citrate increased, showing a mean reduction of 0.2%/0.01 increase in molarity in the citrate reagent. With rising citrate concentration, two laboratories showed a progressive lengthening of the prothrombin time in the plasmas of anticoagulated patients, but one did not. A uniform concentration of trisodium citrate solution should be used: 3.2% trisodium citrate. 2H20 (0.109 M) is suggested. A chart is provided for obtaining a constant proportion between citrate and plasma volumes, from the patient’s haematocrit.
No takes yet. Share an insight, caveat, or question.
Ingram et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: